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aneurysm surgery has reportedly varied from 4% to
more than 40% in the case of extensive type II post-
dissection thoracoabdominal aortic aneurysm.1,2
Obviously, these incidences have made intraopera-
tive spinal cord monitoring an area of interest. Many
factors, such as thrombosis, embolization of the
intercostal arteries during the surgical procedure,
hypoperfusion of the spinal cord during aortic cross-
clamping, and reperfusion injury, can be responsible
for paraplegia. An ischemic insult of sufficient mag-
nitude and duration will produce irreversible motor
neuron injury.
Recently Drenger et al.3 reported the use of con-
tinuous cerebrospinal fluid (CSF) lactate measure-
ments as a possible predictor of an adverse outcome.
An early sensitive marker of spinal cord damage
could be a useful tool in preventing eventual further
deterioration of spinal cord ischemia during and
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Surgical treatment of thoracic and thoracoab-
dominal aortic aneurysms is a major challenge for
both cardiovascular anesthesiologists and surgeons.
Paraparesis and paraplegia are frequent complica-
tions after thoracic aorta cross-clamping. The inci-
dence of paraplegia after thoracoabdominal aortic
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after aortic repair. CSF and serum S-100 protein lev-
els have been used to detect and characterize brain
damage from stroke, subarachnoid bleeding, trau-
ma, or viral infection and to determine compression
of the spinal cord by tumor or spinal cord ischemic
disorders. S-100 protein is released during acute
damage to the central nervous system. S-100 protein
is a calcium-binding acidic protein with a molecular
weight of about 21,000 d that is found in glial and
Schwann cells and that is known to be unique to the
nervous system. The protein is called S-100 because
of its solubility in 100% saturated ammonium sul-
phate at neutral pH. The physiologic role of S-100
protein is still unknown. Both elimination and
metabolization of S-100 protein take place in the
kidney, and the biologic T1/2 is about 2 hours.4
METHODS
Eight patients, seven men and one woman, aged
35 to 75 years (mean, 63 years) who underwent
surgery on the thoracoabdominal aorta were stud-
ied. Before surgery, no patients who were studied
had any neuromuscular disorder. The spinal fluid
drainage and measurements of S-100 protein in CSF
and blood were approved by the Institutional Ethics
Committee, and written informed consent was
obtained from all patients who were scheduled for
aortic repair.
Spinal cord protection during the surgical proce-
dure on the descending thoracic and thoracoab-
dominal aorta was performed by CSF drainage to
keep the CSF pressure between 0 to 10 mm Hg.
Reimplantation of intercostal arteries, left-heart
bypass, and motor-evoked potentials (MEPs) and
somatasensory-evoked potentials (SEPs) were
recorded from the upper and lower extremities at
the right side of the body during the whole proce-
dure. The mean proximal arterial pressure was main-
tained between 60 and 100 mm Hg, and the mean
distal arterial line pressure was kept higher than 60
mm Hg with left-heart bypass. After bypass began,
the aorta was cross-clamped proximally. Staged
clamping was used to maximize the beneficial effect
of the distal perfusion by the left-heart bypass if
aneurysm configuration allowed.
Five arterial blood samples and five CSF samples
were collected for analysis of S-100 protein at the
following times: the first after induction of anesthe-
sia and hemodynamic stabilization, the second dur-
ing the cross-clamp period of the critical segment,
the third after 5 minutes of reperfusion, the fourth
during the closure of the skin, and the fifth at 24
hours after closure of the skin. The serum and CSF
concentrations of S-100 protein were analyzed with
a commercially available immunoradiometric assay
kit (Sangtec Medical AB, Bromma, Sweden). All
samples were analyzed in duplicate. S-100 protein
analysis took 2 hours to run.
No increase in concentration of S-100 protein
could be detected in serum (Table I). In all patients,
the concentration of S-100 protein was increased in
CSF. The highest concentration of S-100 protein
was found in the CSF sample taken after 5 minutes
of reperfusion. The concentration of S-100 protein
in the CSF samples taken at the end of the proce-
dure (sample 4, closure of the skin) and 24 hours
after the repair (sample 5) tended to decrease in all
patients except one. This patient showed increased
concentration of S-100 protein in CSF at the end of
the surgical procedure and after 24 hours.
Adverse events did not occur during the surgical
repair. However, 30 minutes after surgery, in the
intensive care unit (ICU), this patient had atrial fibril-
lation and was hypotensive (mean arterial pressure, 40
mm Hg) for 15 minutes. The patient was diagnosed
with paraplegia on the first postoperative day despite
our combined spinal cord protection techniques.
A high quality of MEP and SEP monitoring dur-
ing the procedure could be accomplished in all
patients. A reduction in spinal cord bloodflow will
Table I. Mean value ± standard deviation of S-100 protein concentration (m g/L) in CSF and serum
All patients except the post- Postoperative paraplegic 
All patients operative paraplegic patient patient 
(n = 8) (n = 7) (n = 1)
CSF Serum CSF Serum CSF Serum
Sample 1 1.29 ± 0.36 <0.2 1.31 ± 0.39 <0.2 1.23 <.02
Sample 2 2.51 ± 1.43 <0.2 2.40 ± 1.54 <0.2 3.16 <0.2
Sample 3 4.20 ± 3.11 <0.2 3.91 ± 3.30 <0.2 5.96 <0.2
Sample 4 3.86 ± 2.69 <0.2 3.50 ± 2.76 <0.2 6.05 <0.2
Sample 5 3.40 ± 3.25 <0.2 2.30 ± 1.57 <0.2 10.03 <0.2
Sample 1, after hemodynamic stabilization; sample 2, during clamping critical aorta segment; sample 3, after 5 minutes of reperfusion;
sample 4, during closure of the skin; sample 5, 24 hours after closure of the skin.
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result in decreased myogenic MEP response within a
few minutes. During the surgical repair, MEP and
SEP monitoring revealed no spinal cord ischemia in
all patients. In the ICU, the CSF pressure was kept
at less than 10 mm Hg, but MEP and SEP monitor-
ing were not performed continuously. 
All patients showed normal MEPs and SEPs on
the first postoperative day except the patient who had
paraplegia. This patient showed normal SEPs, but
showed complete MEP loss in the right leg. Spinal
cord ischemic injury probably developed after the
operation because the MEP and SEP recordings were
normal during surgery. The spinal cord injury may
have been caused by one or more of the following
complications: thrombosis of the intercostal arteries,
the hypotensive period in the ICU, or ongoing reper-
fusion injury (delayed-onset paraplegia) that began in
the operating room and was revealed by S-100 pro-
tein concentration elevation in samples 3 and 4, but
still was undetected by MEP and SEP monitoring.
CONCLUSION
The case of the patient with increasing S-100
protein concentration in CSF in whom paraplegia
developed might be of particular value in clinical
practice. Also, the S-100 protein concentration in
CSF may be an important tool in controlling the
effects of measures, such as long-term neurophysio-
logic monitoring in the ICU and pharmacologic
interventions, to detect and reduce spinal cord dam-
age.
REFERENCES
1. Hollier LH, Money SR, Naslund TC, Procter CD, Buhrman
WC, Marino RJ, et al. Risk of spinal cord dysfunction in
patients undergoing thoracoabdominal aortic replacement.
Am J Surg 1992;164:210-4.
2. Schepens M, Dekker E, Hamerlijnck R, Vermeulen F. Sur-
vival and aortic events after graft replacement for thoracoab-
dominal aortic aneurysms in 172 patients. J Cardiovasc Surg
1996;4:713-9.
3. Drenger B, Parker SD, Frank SM, Beattie C. Changes in
cerebrospinal fluid pressure and lactate concentrations during
thoracoabdominal aortic aneurysm surgery. Anesthesiology
1997;86:41-74.
4. Persson L, Hardemark HG, Gustafson J, Rundstrom G,
Mendel-Hartvig I, Esscher T, et al. S-100 protein and neu-
ron-specific enolase in cerebrospinal fluid and serum: markers
of cell damage in human central nervous system. Stroke
1987;18:911-8.
Don’t miss a single issue of the journal!  To ensure prompt service when you change your address,
please photocopy and complete the form below. 
Please send your change of address notification at least six weeks before your move to ensure continued ser-
vice.  We regret we cannot guarantee replacement of issues missed due to late notification.
JOURNAL TITLE:
Fill in the title of the journal here.
OLD ADDRESS:
Affix the address label from a recent issue of the journal here.
COPY AND MAIL THIS FORM TO: OR FAX TO: OR PHONE:
Journal Subscription Services 314-432-1158 1-800-453-4351
Mosby, Inc. Outside the U.S., call
11830 Westline Industrial Dr. 314-453-4351
St. Louis, MO  63146-3318
NEW ADDRESS:




Send us your new address at least six weeks aheadO N THE MOVE?
